- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT02785315
Cognitive Intervention for Persons With Amnestic Mild Cognitive Impairment
Cognitive Intervention for Persons With Amnestic Mild Cognitive Impairment: The Efficacy in Enhancement of Cognition and Complex Activities of Daily Living Function
People with mild cognitive impairment (MCI) are at a greater risk of developing dementia. Therefore, it is important to develop effective non-pharmacological interventions to facilitate their cognitive and activities of daily living (ADL) function, which will also prevent or delay their progression to dementia and reduce associated healthcare and social costs. There are currently a variety of cognitive interventions, mainly categorized as remediation and rehabilitation approach. Research to compare their contents and effectiveness is strongly needed. The information can be used to individualize cognitive intervention based on specific cognitive profile of the patient.
This study aims to determine the immediate and long-term efficacy of the remediation approach and rehabilitation approach in enhancing the cognitive and ADL function. The research questions include 1) whether the rehabilitation approach compared with the remediation approach has better effects on improving ADL function; (2) whether the remediation approach may only enhance the performance on the cognitive tests rather than on the ADL function. This study will also explore whether the attitudes of caregivers on providing ADL assistance affect effects of cognitive intervention.
Tutkimuksen yleiskatsaus
Tila
Yksityiskohtainen kuvaus
The study is designed by a single-blinded randomized control trial. Sixty persons with MCI, confirmed by physicians, will receive 12 weekly 90-minute cognition interventions in a group of 6-8 persons. All participants will be randomly assigned to the following groups: 1) Remediation approach: various cognitive strategies will be taught, and exercises involving the practice of these strategies to enhance the attention, memory, processing speed, and executive functions. 2) Combination of rehabilitation and remediation approaches: The first half of each session will focus on the remediation approach as described above. The second half of the session will apply rehabilitation approach. The investigators will use group discussion to discuss everyday situations with memory problem and specific strategies (internal and external) related to real-life situations. The investigators will also include one individual session in the 12 group sessions.
All participants will be assessed at 3 time points: before intervention, right after intervention, and 12 weeks after the intervention. The primary outcomes are the ADL functions evaluated by subjective and objective measures, and cognitive function evaluated by tests of attention, memory and executive function. The secondary outcomes include the depression, the quality of life of the participants, and the caregivers' load. The intervention effects will be further analyzed by the caregivers' attitude regarding to the level of ADL assistance.
Opintotyyppi
Ilmoittautuminen (Todellinen)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
-
Taipei, Taiwan, 100
- National Taiwan University Hospital
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Criteria: Inclusion Criteria:
- over 50 years old
- years of education > 6
- mild cognitive impairment diagnosed by physician
- no dementia diagnosis
- Barthel Index scored 100
- Geriatric Depression Scale-Short Form scored < 8
Exclusion Criteria:
- without concurrent major or significant psychiatric disorders
- severe physical diseases which might affect cognitive functions
- difficult to follow instructions due to visual or hearing impairments
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Terveyspalvelututkimus
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Yksittäinen
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
---|---|
Kokeellinen: rehabilitation & remediation approach
The intervention group will receive 12 weekly 90-minute combined cognition interventions in a group.
The first half of each session will be cognitive training which focus on teaching various cognitive strategies and their applications to enhance the attention, memory, processing speed, and executive functions.
The second half of the session will apply rehabilitation intervention with various compensatory strategies.
Investigators will use group discussion to discuss everyday situations with memory problem and specific strategies (internal and external) related to real-life situations.
Investigators will also include one individual session in the 12 group sessions.
|
The rehabilitation & remediation approach group will receive 12 weekly 90-minute combined cognition interventions in a group.
The first half of each session will be cognitive training which focus on teaching various cognitive strategies to enhance the attention, memory, processing speed, and executive functions.
The second half of the session will apply rehabilitation intervention by discussing everyday situations with memory problem and specific strategies related to real-life situations.
Investigators will also include one individual session in the 12 group sessions.
|
Active Comparator: remediation approach
The remediation approach will receive 12 weekly 90-minute cognitive training which focus on teaching various cognitive strategies and their applications to enhance the attention, memory, processing speed, and executive functions.
|
The remediation approach will receive 12 weekly 90-minute cognitive training which focus on teaching various cognitive strategies and their applications to enhance the attention, memory, processing speed, and executive functions.
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Aikaikkuna |
---|---|
Change from Baseline The Brief University of California San Diego (UCSD) Performance-Based Skills Assessment (Traditional Chinese Version)(UPSA-Brief ) at the 12th and 24th weeks
Aikaikkuna: baseline, 12th and 24th weeks after intervention
|
baseline, 12th and 24th weeks after intervention
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
---|---|---|
Change from Baseline Short-form Zarit Caregiver Burden Interview-12 (sCZBI-12) at the 12th and 24th weeks
Aikaikkuna: baseline, 12th and 24th weeks after intervention
|
baseline, 12th and 24th weeks after intervention
|
|
Change from Baseline Montreal Cognitive Assessment (MoCA) Taiwan Version at the 12th and 24th weeks
Aikaikkuna: baseline, 12th and 24th weeks after intervention
|
baseline, 12th and 24th weeks after intervention
|
|
Change from Baseline Word Sequence Learning Test at the 12th and 24th weeks
Aikaikkuna: baseline, 12th and 24th weeks after intervention
|
baseline, 12th and 24th weeks after intervention
|
|
Change from Baseline Minimal-Mental Status Exam (MMSE) at the 12th and 24th weeks
Aikaikkuna: baseline, 12th and 24th weeks after intervention
|
baseline, 12th and 24th weeks after intervention
|
|
Change from Baseline Miami Prospective Memory Test (MPMT) at the 12th and 24th weeks
Aikaikkuna: baseline, 12th and 24th weeks after intervention
|
baseline, 12th and 24th weeks after intervention
|
|
Change from Baseline Color Trails Test at the 12th and 24th weeks
Aikaikkuna: baseline, 12th and 24th weeks after intervention
|
baseline, 12th and 24th weeks after intervention
|
|
Change from Baseline Structure MRI at the 12th and 24th weeks
Aikaikkuna: baseline, 12th and 24th weeks after intervention
|
baseline, 12th and 24th weeks after intervention
|
|
Change from Baseline PiB-PET and FDG-PET at the 12th and 24th weeks
Aikaikkuna: baseline, 12th and 24th weeks after intervention
|
PiB-PET: Pittsburgh Compound B-Positron Emission Tomography FDG-PET:18-Fluoro-deoxyglucose positron emission tomography
|
baseline, 12th and 24th weeks after intervention
|
Change from Baseline amyloid Aβ40, Aβ42 and tau proteins at the 12th and 24th weeks
Aikaikkuna: baseline, 12th and 24th weeks after intervention
|
baseline, 12th and 24th weeks after intervention
|
|
Change from Baseline The Disability Assessment for Dementia (DAD) at the 12th and 24th weeks
Aikaikkuna: baseline, 12th and 24th weeks after intervention
|
baseline, 12th and 24th weeks after intervention
|
|
Change from Baseline Quality of Life-Alzheimer's Disease scale (QoL-AD) at the 12th and 24th weeks
Aikaikkuna: baseline, 12th and 24th weeks after intervention
|
baseline, 12th and 24th weeks after intervention
|
|
Change from Baseline Goal Attainment Scaling (GAS) at the 12th and 24th weeks
Aikaikkuna: baseline, 12th and 24th weeks after intervention
|
baseline, 12th and 24th weeks after intervention
|
|
Change from Baseline Everyday Memory Questionnaire at the 12th and 24th weeks
Aikaikkuna: baseline, 12th and 24th weeks after intervention
|
baseline, 12th and 24th weeks after intervention
|
Yhteistyökumppanit ja tutkijat
Sponsori
Tutkijat
- Päätutkija: Hui-Fen Mao, National Taiwan University Hospital
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Arvio)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- 201402028RINC
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .
Kliiniset tutkimukset Lievä kognitiivinen heikentyminen
-
Dart NeuroScience, LLCValmisAge-Associated Memory Impairment (AAMI)Yhdysvallat
-
TakedaValmisPost-Stroke Cognitive Impairment (PSCI)Valko-Venäjä, Kazakstan, Venäjän federaatio
Kliiniset tutkimukset rehabilitation & remediation approach
-
Farapulse, Inc.ValmisParoksismaalinen eteisvärinäRanska
-
University of Illinois at ChicagoRekrytointiKohdunkaulansyöpä | KäyttäytyminenSenegal
-
University of Texas at AustinNational Institute on Drug Abuse (NIDA)ValmisNikotiiniriippuvuusYhdysvallat
-
Johns Hopkins Bloomberg School of Public HealthUnited States Agency for International Development (USAID)ValmisMasennus | Posttraumaattinen stressihäiriöUkraina
-
Xuanwu Hospital, BeijingThe Second Hospital of Hebei Medical University; The First Affiliated Hospital... ja muut yhteistyökumppanitTuntematonAtlantoaksiaaliseen dislokaatioon liittyvä basilar-invaginaatioKiina
-
VA Office of Research and DevelopmentValmisPääteolosuhteet, käyttöiän loppuYhdysvallat
-
Farapulse, Inc.ValmisParoksismaalinen eteisvärinäTšekki, Ranska
-
Xuanwu Hospital, BeijingThe Second Hospital of Hebei Medical University; The First Affiliated Hospital... ja muut yhteistyökumppanitTuntematonAtlantoaksiaaliseen dislokaatioon liittyvä basilar-invaginaatioKiina
-
Western UniversityRekrytointiDiabetes mellitus, tyyppi 2 | Istuva käyttäytyminen | Aikuinen KAIKKIKanada
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...Ei vielä rekrytointia